Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients

被引：28

作者：

Rocio, Carolina ^{[1
]}

Amato, Valdir Sabbaga ^{[1
]}

Camargo, Raphael A. ^{[1
]}

Tuon, Felipe F. ^{[2
]}

Nicodemo, Antonio Carlos ^{[1
]}

机构：

[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil

[2] Univ Fed Parana, Clin Univ Hosp, Div Infect Dis, BR-80060000 Curitiba, PR, Brazil

来源：

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2014年 / 108卷 / 03期

关键词：

Amphotericin B; Leishmania treatment; Leishmaniasis;

D O I：

10.1093/trstmh/tru011

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Background: Studies assessing the efficacy of liposomal amphotericin B (LAB) in the treatment of patients with mucosal leishmaniasis (ML) are very scarce in the literature and an optimal dose regimen has not yet been defined. Methods: We performed a retrospective and descriptive analysis from records of 16 patients with ML treated with LAB. The mean daily dose of LAB was 2.5 mg/kg/day. Results: Healing of the lesion was observed in 14 (88%) of the 16 patients. The mean cumulative doses, excluding the two treatment failures, were 2265 mg and 33 mg/kg. Conclusion: Liposomal amphotericin B in the cumulative dose of 30 to 35 mg/kg was able to achieve 100% effectiveness.

引用

页码：176 / 178

页数：3

共 50 条

[31] Visceral leishmaniasis treated with liposomal amphotericin B
Catania, S
Aiassa, C
Tzahtzoglou, S
Catania, N
Tucciarone, L
Antimi, A
Ragni, G
Clerico, A
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (01) : 73 - 75
[32] A Case of Cutaneous Leishmaniasis Responding to Systemic Liposomal Amphotericin B Treatment
Taskin, Esra Cakmak
Kutukcu, Hatice Busra
Konca, Hatice Kubra
Arga, Gul
Ozdemir, Halil
Akay, Bengu Nisa
Ciftci, Ergin
Ince, Erdal
JOURNAL OF PEDIATRIC INFECTION, 2020, 14 (04): : 247 - 250
[33] Liposomal amphotericin B to treat visceral leishmaniasis
Monge-Maillo, Begona
Lopez-Velez, Rogelio
REVISTA IBEROAMERICANA DE MICOLOGIA, 2021, 38 (02): : 101 - 104
[34] Development of liposomal amphotericin B formulation
Gulati, M
Bajad, S
Singh, S
Ferdous, AJ
Singh, M
JOURNAL OF MICROENCAPSULATION, 1998, 15 (02) : 137 - 151
[35] Mucocutaneous leishmaniasis treated with liposomal amphotericin B
Lambertucci, Jose Roberto
dos Santos Silva, Luciana Cristina
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2008, 41 (01) : 87 - 88
[36] Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis
Brown, M
Noursadeghi, M
Boyle, J
Davidson, RN
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 203 - 205
[37] SUCCESSFUL TREATMENT OF RESISTANT VISCERAL LEISHMANIASIS WITH LIPOSOMAL AMPHOTERICIN-B
GOKHALE, PC
KSHIRSAGAR, NA
KHAN, MU
PANDYA, SK
MEISHERI, YV
THAKUR, CP
CHOUDHARY, CB
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (02) : 228 - 228
[38] Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
Solomon, M.
Pavlotsky, F.
Leshem, E.
Ephros, M.
Trau, H.
Schwartz, E.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (08) : 973 - 977
[39] Gingival leishmaniasis in an HIV-negative patient
Palmeiro, Mariana Reuter
Valette Rosalino, Claudia Maria
Quintella, Leonardo Pereira
Morgado, Fernanda Nazare
da Costa Martins, Ana Cristina
Moreira, Joao
Schubach, Armando de Oliveira
Conceicao-Silva, Fatima
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (06): : E12 - E16
[40] Liposomal amphotericin B for visceral leishmaniasis in HIV-coinfected patients: 2-year treatment outcomes in Bihar, India
Sinha, K.
van Griensven, J.
Pandey, K.
Kumar, N.
Verma, N.
Mahajan, R.
Kumar, P.
Kumar, R.
Das, P.
Mitra, G.
Flevaud, L.
Ferreyra, C.
Remartinez, D.
Pece, M.
Palma, P. P.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 189 - 189

← 1 2 3 4 5 →